AXIM Biotechnologies, Inc. (AXIM) .
本頁證實的標準:
SharesGrow 綜合評分： 21/100 其中 1/7 項標準通過。
| Year | EPS（稀釋） | 營收 | 淨利潤 | 淨利潤率 |
|---|---|---|---|---|
| 2015 | $-0.27 | $49.14K | $-10.09M | -20539.2% |
| 2016 | $-0.14 | $47.06K | $-5.81M | -12346% |
| 2017 | $-0.08 | $47.57K | $-4.17M | -8761.7% |
| 2018 | $-0.12 | $195.61K | $-6.75M | -3453% |
| 2019 | $-0.11 | $799.48K | $-6.77M | -847% |
| 2020 | $-0.06 | $0.00 | $-6.73M | - |
| 2021 | $-0.13 | $60.46K | $-16.52M | -27320.8% |
| 2022 | $-0.04 | $8.88K | $-5.96M | -67120.7% |
| 2023 | $-0.04 | $39.52K | $-8.06M | -20395% |
| 2024 | $-0.01 | $70.46K | $-3.51M | -4985.2% |
